Invivyd doses first participants in Phase 3 COVID-19 trial

Invivyd Inc (NASDAQ:IVVD) has dosed the first participants in its LIBERTY Phase 3 trial, a study testing the company's ...

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to ...

LIBERTY clinical trial will evaluate the comparative safety and tolerability of VYD2311 versus mRNA COVID-19 vaccine, as well as explore the ...

Cancer vaccines based on mRNA advance, despite US cuts

By Julie Steenhuysen CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 ...
Devdiscourse

Revolutionary mRNA Cancer Vaccines: A New Hope in Oncology

RNA technology, which expedited COVID-19 vaccines, is showing promise against formidable cancers like melanoma and pancreatic ...

Pfizer didn't say hantavirus is side effect of its COVID-19 vaccine, contrary to online claims

Those eager to discredit Pfizer's mRNA vaccine, which is safe and effective, exploited the cruise ship outbreak.
Time

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry

BioNTech co-founders Dr. Ugur Sahin and Dr. Ozlem Tureci in its headquarters in Germany on Jan. 3.Photograph by Dina Litovsky—Redux for TIME “No!” The doctor snapped. “Look at me!” I had been staring ...

'Spike proteins in tumor?': Chilling claim on 'mRNA COVID vaccines causing Cancer' at Senate hearing

Wis., held a high-stakes hearing on Capitol Hill Wednesday, focusing on COVID-19 and allegations that federal health agencies ...

The COVID-19 vaccine Australians can't get

The new Novavax XBB.1.15 vaccine appears to have been knocked back for approval by the Therapeutic Goods Administration.

Focus: Cancer vaccines based on mRNA advance, despite US cuts

Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting ...